UCLA Researchers Develop Low-Cost Blood Test to Detect Multiple Cancers And Other Diseases From a Single Sample

oncodaily - The new method analyzes genome-wide methylation of DNA circulating in the bloodstream to detect liver, lung, ovarian and stomach cancers, as well as several non-cancer conditions. UCLA scientists have developed […]

AI Summary: Researchers at UCLA introduced a low-cost blood test capable of detecting multiple cancers and other diseases from a single sample, promising broader screening reach and earlier detection. If validated at scale, the technology could lower barriers to multi-cancer screening, reshape diagnostic pathways, and offer cheaper, simpler surveillance—assuming the usual caveats about follow-up testing and false positives.

• Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions (4)
• On location: early-detection debates, AI risk stratification and screening value (4)
• On the ground: UCLA’s inexpensive blood test expands multi-disease detection (4)
• All Other Stories

Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions

On location: early-detection debates, AI risk stratification and screening value

On the ground: UCLA’s inexpensive blood test expands multi-disease detection

All Other Stories